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A statistically significant difference in mean values between two
laboratory quantitation methods is interpreted as a bias. Sometimes
such a difference is so minute that it does not constitute anypractical
concern. An alternative approach is to test statistically whether the
two methods are close enough, notfor equality. This is to look at the
confidence interval of the mean method difference and does not
entail any additional statistical tests.
Introduction
When comparing a new laboratory quantitation method
to a standard method, the new method ideally should give
the same, if not more accurate, results than the standard
method. Any systematic difference between the two
methods is called a bias. The conventional statistical
evaluation ofbias is by testing the null hypothesis that the
quantitation result from the new method equals that of
the standard one. The methodology for comparing two
means is given in most statistical references, for example
see Snedecor and Cochran, chapter 4 [1].
One concludes that the new method is biased if the test
statistic is significant at the 0-level, where 0 is the type I
error chosen by the investigator, for example 0 0"05.
The test statistic is usually of the form:
d/SE(d) (1)
where d is the mean method difference and SE(d) is the
standard error of d.
Sometimes a statistically significant difference, d, is so
small in magnitude that it does not materially affect the
quantitation ofsamples. Such a difference is not meaning-
ful in laboratory practice.
Indeed, one can argue that because the new and standard
methods are not identical, given enough samples, one can
always demonstrate that there is a bias with the new
method. The new method is penalized because ofthe high
precision in our statistical evaluation process. An alterna-
tive approach in statistical evaluation is clearly needed in
this instance.
Method
The idea of testing two mean values for being similar but
not necessarily identical is not new. In the pharmaceut-
ical industry, two formulations of a drug are said to be
bioequivalent if their mean values with respect to some
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clinical or pharmacokinetic parameter are close enough
[2]. The same concept can be applied to comparing two
laboratory quantitation methods: two methods are said to
be ’equivalent’ if their mean difference is less than a
prescribed quantity, say H, which is called the maximum
acceptable difference. H could be chosen from experience
or be a value deemed practical by the investigator.
Statistically one accepts the equivalence of two labora-
tory methods at the 0Mevel if the (1-0) 100% confidence
interval of the mean method difference d, say (C1, C2), is
completely contained in the interval (-H, H), i.e.
-H < C1 < d < C2 < H (2)
If the method difference is assumed to be normally
distributed then the test statistic (equation [1]) is a
t-distribution, and the (1-0) 100% confidence interval ofd
is:
c, c u + t/,, sw(u) (a)
where, is the degrees offreedom ofSE(d) and t/2, is the
(1-o/2)- 100 percentile ofthe t-distribution with v degrees
of freedom.
The above test procedure is also applicable when there is
only one laboratory method. Sometimes one wants to test
whether the laboratory method is accurate enough with
respect to a known target value, say T. LetX be the mean
value ofthe laboratory method, then d X- Tand SE(d)
SE(X), and the test procedure is the same as described
above. For example the laboratory method is a HPLC
assay measuring the recovery of a chemical entity. The
natural target value (T) will be 100% in this instance.
The two methods case can sometimes be reduced to a one
method situation. If the ratio, instead of the difference, of
the two methods is being investigated and assumed to be
Normally distributed, thenX mean ratio and the target
T 100% again. This situation will be illustrated in the
next section.
Example
To illustrate the test of equivalence, an example has
been taken from Griffiths et al. [3]: the potassium levels of
21 patient serum specimens were analysed by Beckman
Astra-8 and flame photometry methods. The Astra
method was arbitarily defined as the standard method,
and the flame photometry as the new method. The ratio
of the new method to the standard method (expressed in
%) was assumed to be normally distributed and was used
to evaluate bias of the new method. The raw data and the
ratio are reproduced in table 1.K. F. Yee Evaluation bias in laboratory methods
Table 1. Raw datafor potassium by two quantitative methods and
their ratio (see Griffits et al. [3]).
Sample Astra Flame %
2.4 2"4 100.0
2 4.8 4.8 100.0
3 4.0 4.0 100.0
4 4.6 4.7 102.2
5 3.9 3.9 100.0
6 4.1 4.2 102.4
7 3"8 3"8 100.0
8 3’2 3.3 103.1
9 4.6 4.6 100.0
10 2"9 3.0 103.4
11 4.9 5"0 102’0
12 3.5 3.6 102.9
13 4.8 4.9 102.1
14 3"7 3.8 102.7
15 3.8 3.9 102.6
16 4.5 4.6 102’2
17 4.2 4.2 100.0
18 4"2 4.2 100.0
19 4.3 4.4 102.3
20 3.9 4.0 102.6
21 3"3 3.4 103.0
Mean 101’6
SD 1"33
SE of mean 0"29
95% confidence 101 ’0
Interval of mean 102’2
The target value T 100%. From table 1, d 101"6-100
1"6%, SE(d) 0"29%. In the conventional significance
test approach, the test statistic:
d/SE(d) 1"6/0"29 5"52 with 20 degrees of freedom
was highly significant (the critical value at 0 0’05 and
20 degrees of freedom is 0.025,20 2"086), i.e. the flame
photometry was biased in that its measurement was on
average 1.6% higher than that of the Astra method.
However, if one feels that only method differences
exceeding a certain level constitute meaningful difference,
then the test of equivalence approach will be more
appropriate. From equation (3) the 95% confidence
interval of d: 1"6 + 2"086 x 0"29 (1"0, 2’2). Various
levels of the maximum acceptable difference, H, have
been chosen to demonstrate the interpretation of the test
of equivalence at o 0"05. Figure illustrates these
situations.
() /4 0.5
The 95% confidence interval of d was completely
outside the interval (-0"5, 0"5). The flame photo-
metry method gave significantly higher results than
the Astra method by 0"5% or more. The conclusion is
the same as the conventional significance test in this
instance, i.e. not equivalent.
(1) tt 0.s
Not equivalent
(2) H 1.5
Inconclusive
(3) H 3.0
Equivalent
-3 -2 -1 0 d 2 3
Figure 1. The test of equivalence between the Astra and Flame
methods for various maximum acceptable differences, H. { } is
the 95% confdence interval of the mean difference d.
(2) H 1.5
The 95% confidence interval of d overlapped the
interval (- 1.5, 1"5). There was inconclusive evidence
to discern the equivalence of the two methods, one
way or the other. It indicates that more samples are
required to reach any conclusion at this significance
level.
() H .0
The 95% confidence interval of d was completely
contained in the interval (-3,3). The flame photo-
metry method was equivalent to the Astra method in
that the results ofeach differed from the other by less
than 3%.
Discussion
One can argue that there is always a bias between two
laboratory quantitation methods. A statistically signifi-
cant difference between methods is of acadmic interest
only, unless the magnitude of the difference also has a
practical implication. A dogmatic application of the
conventional significance test might not give a meaning-
ful interpretation. In contrast, the test of equivalence
provides wider scope, and sometimes a more realistic
approach in comparing two methods. No additional
statistical test is needed in this evaluation procedure.
The choice of the maximum acceptable difference, H, is
crucial in the successful application of the test of
equivalence. This is not a statistical decision, but one
which must be determined from experience, or a value
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which is deemed meaningful from the practitioner’s
perspective.
When there is inconclusive evidence to detect whether
two methods are equivalent, more samples are needed in
the test. The methodology for determining the optimal
sample size in a comparative experiment using the
conventional significance test is well known [1], but the
calculation is far more complex in the equivalence test
context [4], and is beyond the scope of this note.
So far only the case where data are normally distributed
has been illustrated. There is no difficulty in applying the
equivalence test idea to data having other types of
distribution so long as the confidence interval ofthe mean
method difference can be obtained.
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INDUSTRY SCOREBOARD--1988
A world-wide ranking of analytical instrument firms has recently been published by the Analytical Instrument Industry Report.
Full copies of the analysis, which broadly estimates sales of product and service to analytical laboratories in 1987 for 165
companies, are available from Gordon Wilkinson, AIIR, PO Box 78, East Grinstead RH19 2YW, UK. The following is an extract
from AIIR’s analysis:
Where leading companies disclose analytical product group sales, this usually includes instruments, accessories, supplies,
data systems, and service revenues.
AIIR therefore included a selection ofsmaller companies that also make these supplies. Your familiarity with the industry will
enable you to assess the relevant business areas in which these firms compete. AIIR’s definition ofanalytical instrumentation
includes surface analysis and electron-optic products.
Note: companies are arranged in alphabetical order in each range.
400-450 Perkin-Elmer (USA)
350-400 Hewlett-Packard (USA)
Shimadzu (Japan)
250-300 JEOL (Japan)
Philips Analytical (The Netherlands)
200-250 Hitachi (Japan)
Pharmacia/LKB (Sweden)
Waters Chromatography Division/Millipore (USA)
150-200 Rigaku (Japan)
Varian (USA)
100-150 Bruker (FRGermany)
Finnigan (USA)
Fisons, including ARL, CEST,J&W (UK)
VG Instruments [SEM + MS] (UK)
These industry leaders currently account for almost $3 billion worth of sales. Of this group, five are US-owned, five are
European and four are Japanese.
Japanese firms again have relatively higher rankings this year, primarily because of the continuing appreciation of the yen
against the dollar since September 1985. In real terms, however, their sales have been badly hit in the past year.
Companies with sales in the $40 million to $100 million range appear in the following table. Of these, 16 are US-owned, six
are European, and four are Japanese.
Report continued with $40-100 M rankings on page 157
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